Belongs to

• Solid Tumor Oncology Division

Types of Work

["2020"]

[[["Journal Articles",899],["Meeting Abstracts",613],["Book Sections",41],["Reviews",31],["Editorials",19],["Guidelines",12],["Correspondences",3],["Books Whole",1],["Miscellaneous",1],["Research Letters",1]]]

[1621]

Popular keywords

• adult
• aged
• article
• cancer survival
• female
• human
• major clinical study
• middle aged
• paclitaxel
• priority journal

Recent Works

1. Time to deterioration in quality of life in patients (pts) with advanced endometrial cancer (aEC) treated with lenvatinib plus pembrolizumab (L+P) or treatment of physician's choice (TPC)

   Meeting Abstract

   Lorusso, D.; Colombo, N.; Herraez, A. C.; Santin, A. D.; Colomba, E.; Miller, D. S.; Fujiwara, K.; Pignata, S.; Baron-Hay, S. E.; Ray-Coquard, I. L.; more...
   Annals of Oncology (2022)

   Fulltext@MSK | Save
2. Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets

   Journal Article

   Nacev, B. A.; Sanchez-Vega, F.; Smith, S. A.; Antonescu, C. R.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N. D.; Rana, S.; Zehir, A.; more...
   Nature Communications (2022)

   Fulltext@MSK | Save
3. Olaparib with or without cediranib versus platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer (NRG-GY004): A randomized, open-label, phase III trial

   Journal Article

   Liu, J. F.; Brady, M. F.; Matulonis, U. A.; Miller, A.; Kohn, E. C.; Swisher, E. M.; Cella, D.; Tew, W. P.; Cloven, N. G.; Muller, C. Y.; more...
   Journal of Clinical Oncology (2022)

   Fulltext@MSK | Save